Current situation of hepatocellular carcinoma in Mongolia

Oncology

Volumn 81, Issue SUPPL. 1, 2011, Pages 148-151

  Baatarkhuu, Oidov ^a   Kim, Do Young ^c   Bat Ireedui, Purevbaatar ^b   Han, Kwang Hyub ^c  

^a MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^b National Cancer Center   (Mongolia)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Mongolia; Viral hepatitis

Indexed keywords

ALPHA FETOPROTEIN;

ADVANCED CANCER; ANTIVIRAL THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; EARLY DIAGNOSIS; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MONGOLIA; MORBIDITY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MONGOLIA; PALLIATIVE CARE; PREVALENCE;

EID: 84855331366     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000333278     Document Type: Review

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
2. El-Serag HB, Rudolph KL: Hepatocellular carcinoma; epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576. (Pubitemid 46890874)
3. El-Serag HB: Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35(suppl 2):572-578.
4. Jernal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
5. Liovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003;362:1907-1917. (Pubitemid 37518510)
6. Yoshizawa H: Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002;62(suppl 1):8-17.
7. World Health Organization: Hepatitis B vaccine. Wkly Epidemiol Rec 2004;79:263.
8. Global surveillance and control of hepatitis C: report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgum. J Viral Hepat 1999;6:35-47.
9. Donato F, Tagger A, Gelatti U et al: Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and woman. Am J Epidemiol 2002;155:323-331. (Pubitemid 34132050)
10. Gelatti U, Covolo L, Franceschini M, et al: Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study J Hepatol 2005;42:528-534. (Pubitemid 40342932)
11. Mongolian National Statistical Office Bulletin December 2006. 2006. http://202.131.5.91/bulletin-2006-dec.pdf.
12. World Health Organization: The work of WHO in the Western Pacific region 2003-2004: report of the Regional Director to the Regional Committee for the Western Pacific, statistical annex. Manila, WHO, 2003, pp 190-205.
13. Mongolia Today: Country briefs. 2002. http://www.mongoliatoday.com/info/ country-briefs.html.
14. Health Indicators. Mongolia, National Health Development Center, 2004.
15. Nymadawa P: Hepatitis B vaccination: worldwide and in Mongolia. Abstracts 10th Nat Conf 'Current Topics of Virology'. Ulaanbaatar, 2004, pp 115-116.
16. Baatarkhuu O, Kim DY, Ahn SH, et al: Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. Liver Int 2008;28:1389-1395.
17. Cohen J: The scientific challenge of hepatitis C. Science 1999;285:26-30.
18. Stark K, Poggensee G, Hohne M, Bienzle U, Kiwelu I, Schreier E: Seroepidemiology of TT virus, GBV-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania. J Med Virol 2000;62:524-530.
19. Frank C, Mohamed MK, Strickland GT, et al: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887-891. (Pubitemid 30137669)
20. Davaalkham D, Ojima T, Nymadawa P, et al: Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 2006;78:466-472. (Pubitemid 43346897)
21. Ebright JR, Altantsetseg T, Oyungerel R: Emerging infectious diseases in Mongolia. Emerg Infect Dis 2003;9:1509-1515. (Pubitemid 37505443)
22. Tsatsralt-Od B, Takahashi M, Nishizawa T, et al: High prevalence of hepatitis B, C, and delta virus infections among blood donors in Mongolia. Arch Virol 2005;150:2513-2528. (Pubitemid 41642139)